S&P 500 Snaps Losing Streak as Yield Relief Lifts Healthcare
The S&P 500 closed up 0.24% at 7,709.91 on Wednesday, snapping a three-session losing streak after the Treasury Department said it would double buyback operations for longer-dated bonds. The move pulled the 30-year Treasury yield down to 5.194% from Tuesday's 19-year high of 5.327%, and stocks followed the bond market higher.
The shape of the rally mattered more than its size. Healthcare did essentially all the heavy lifting: XLV climbed to a fresh record after Moderna's personalized mRNA melanoma therapy, developed with Merck, cut recurrence risk in a late-stage trial. Merck was the Dow's top gainer on the news.
Technology told a different story. The Philadelphia Semiconductor Index closed lower even as the broader tape rose, and Alphabet shares barely moved despite a pop in Marvell on a new custom-silicon partnership with Google. When the sector most sensitive to falling yields fails to join the bounce, that is a breadth question, not a green light for a durable turn.
Options markets read the moment as calm. The VIX round-tripped from a spike above 15.8 back to 14.89, down 6% into Thursday's premarket, with futures pointing to a modestly higher open. The VIX put/call ratio sits at 0.44, down sharply from 0.71 a year ago, a positioning backdrop that looks complacent given how fast volatility has swung over the past week.
Wednesday's bounce leaned defensive. Healthcare and quality led while the rate-sensitive sectors that should benefit most from lower yields stayed on the sidelines. Whether that becomes a genuine multi-week rotation, or reverts the moment a hawkish inflation print reopens the yield debate, is the question to track into Thursday's session and beyond. MarketIntelLabs Premium subscribers can find the full sector-rotation breakdown, including what a durable healthcare-led shift would need to show and how the FOMC's hawkish July minutes fit into the setup, in today's deeper positioning analysis.
This content is for informational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Consult a qualified financial advisor before making investment decisions.
Related Reading
Get daily intelligence delivered
Create a free account for the Daily Brief every weekday and The Week Ahead every Sunday. No card required.